CorMedix Inc.
(NYSE Amex Equities : CRMD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.59%84.230.6%$473.31m
ABTAbbott Laboratories
1.40%73.900.8%$396.32m
TMOThermo Fisher Scientific Inc.
0.91%259.861.0%$393.97m
ISRGIntuitive Surgical, Inc.
0.58%528.062.4%$335.04m
BDXBecton, Dickinson and Company
0.91%227.931.1%$320.84m
ALGNAlign Technology, Inc.
2.85%281.496.3%$293.23m
BSXBoston Scientific Corporation
0.57%35.111.1%$279.52m
SYKStryker Corporation
-0.03%180.181.3%$219.72m
BAXBaxter International Inc.
-0.07%74.341.7%$217.99m
ABMDABIOMED, Inc.
2.02%256.563.3%$211.84m
EWEdwards Lifesciences Corporation
-0.12%177.281.2%$199.99m
DXCMDexCom, Inc.
2.61%114.298.5%$177.08m
ZBHZimmer Biomet Holdings, Inc.
0.24%119.981.7%$135.05m
WATWaters Corporation
0.64%239.613.5%$108.39m
TNDMTandem Diabetes Care, Inc.
-1.63%54.414.1%$97.73m

Company Profile

CorMedix, Inc. operates as a pharmaceutical and medical device company, which seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The firm is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.